Table 1 Effect of supervision on patient health outcomes
Study | N | Measure | Method | Results: Supervision vs. Control (SMD > 0 favours supervision) (OR >1 favours supervision) |
|---|---|---|---|---|
Bambling et al. 2006 [22] | 103 | Depression severity | Beck Depression Inventory | Skills Foci Supervision BDI SMD 0.50 (95%CI 0.02 to 0.99) Process Foci Supervision BDI SMD 0.76 (95%CI 0.28 to 1.24) |
Bradshaw et al. 2007 [23] | 93 | Psychiatric symptoms in individuals experiencing psychotic symptoms | Krawiecka, Goldberg and Vaughan symptom scale (KGV) | KGV Affective Symptoms SMD 0.32 (95%CI −0.10 to 0.73) KGV Positive Symptoms SMD 0.48 (95%CI 0.06 to 0.90) KGV Negative Symptoms SMD 0.06 (95%CI −0.36 to 0.47) KGV Total Symptom Score SMD 0.47 (95%CI 0.06 to 0.89) |
Couper et al. 2015 [26] | 746 | Neurologic Outcome | Cerebral Performance Category (CPC) Score; analysed dichotomously as good (CPC 1 or 2) OR poor (CPC 3, 4 or 5) | Good Neurologic Outcome OR 1.02 (95%CI 0.70 to 1.48) |
Martino et al. 2016 [24] | 385 | Days of primary substance abuse abstinence | Self-report of substance abuse utilising the substance use calendar | SMD −0.06 (95%CI −0.26 to 0.14) |
Pozen et al. 1976 [25] | 300 | Faculty member ratings of patient outcomes, including patient symptoms function and health status | Medical record review, patient questionnaire and 8-month follow-up assessment | N/Sa |
Wolfe et al. 2014 [27] | 119 | Neurologic Outcome | Paediatric Cerebral Performance Category (PCPC) Score; analysed dichotomously as favourable (PCPC score 1–3 OR no change from admission score) or non-favourably (PCPC score 4–6) | Favourable Neurologic Outcome OR 2.47 (95%CI 1.05 to 5.78) |